In a recently published study, Luo et al. (2020) disclosed that NSE level was significantly associated with tumor stage, lymph node, and distant metastasis of CRC patients, suggesting that NSE could be used as a progression biomarker of CRC. The gene discussed is ENO2; the disease is colorectal carcinoma.